Braxia Scientific Corp.: Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals

Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoYToronto, Ontario--(Newsfile Corp. - March 1, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960),

Related Keywords

Florida ,United States ,California ,Montreal ,Quebec ,Canada ,Toronto ,Ontario ,Ottawa ,America ,Canadian ,American ,Roger Mcintyre ,Dennis Riedl ,Rogers Mcintyre ,Irwin Naturals Inc ,Braxia Health ,Braxia Scientific Corp ,United States District Court ,Newsfile Corp ,Excellence Inc ,International Clinical Research Services ,Health Canada ,Canadian Rapid Treatment Center ,Irwin Naturals ,Electronic Document Analysis ,North American ,Arrangement Agreement ,North America ,Clinical Research Services ,Proposed Transaction ,Central District ,Braxia Shares ,Controlled Drugs ,Substances Act ,Restated Listing Statement ,Braxia ,Cientific ,Orp ,Reports ,023 ,Financial ,Results ,Rovides ,Update ,Cquisition ,Under ,Darwin ,Naturals ,